Kalayoglu Murat
SEC insider (Form 3/4/5 filer). CIK 0002000002. 10% Owner at Cartesian Therapeutics, Inc. (RNAC). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 2, 2026. Located in WASHINGTON, DC.
Companies Kalayoglu Murat has filed insider reports for
- Cartesian Therapeutics, Inc. (RNAC): 10% Owner
Kalayoglu Murat
CIK: 0002000002
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (50.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNAC
Cartesian Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 2, 2026RNAC
Cartesian Therapeutics, Inc.
ExerciseIndirect758K shares- - Jan 2, 2026RNAC
Cartesian Therapeutics, Inc.
AwardDirect2.6K shares- - Jan 2, 2025RNAC
Cartesian Therapeutics, Inc.
AwardDirect2.6K shares- - Oct 11, 2024RNAC
Cartesian Therapeutics, Inc.
ExerciseIndirect1.5M shares-
1-4 of 4 transactions